Achin Gupta
-
Sanofi, Cipla to expand reach of CNS portfolio in India
Cipla will be responsible for the distribution of Sanofi India’s six CNS brands including Frisium Sanofi India and Cipla announced…
Read More » -
Cipla launches Cippoint, a point-of-care device for NCDs, infectious diseases
Cippoint, an immunofluorescence-based quantitative analyser, will allow healthcare professionals to get test results in three to 15 minutes Cipla announced…
Read More »
